Artemis Medicare Services Ltd

The Sensex edged up 0.37% on 5 Aug 2026, while Artemis Medicare Services Ltd surged 7.14%, touching an intraday high of Rs 323. This 7.49-percentage-point outperformance over its Hospital sector peers highlights a distinctly stock-specific rally rather than a broad market lift.

Surging to an intraday peak of Rs 312 on 5 Aug 2026, Artemis Medicare Services Ltd has marked a fresh 52-week high, extending its impressive 23.74% return over the past year. This milestone comes amid a backdrop of strong technical momentum and a market environment where the Sensex trades near its own recent peaks.

Artemis Medicare Services Ltd is rated Buy by MarketsMOJO, with this rating last updated on 08 June 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock’s current position as of 04 August 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Artemis Medicare Services Ltd., a Gurugram-based multi-speciality hospital operator, delivered an impressive first quarter for FY2027, posting consolidated net profit of ₹31.31 crores, marking a sequential growth of 4.26% from Q4 FY26 and a robust year-on-year surge of 47.13%. The small-cap healthcare provider, with a market capitalisation of ₹4,814.88 crores, has seen its stock rally 9.72% over the past week, currently trading at ₹304.15, just shy of its 52-week high of ₹308.60.

With a decisive break above Rs 308.05 on 4 Aug 2026, Artemis Medicare Services Ltd has reached a fresh 52-week high, extending its impressive 21.76% return over the past year. This milestone is underscored by a strong alignment of technical indicators and sustained price momentum, setting the stock apart in the hospital sector amid a broadly positive market backdrop.

Surging to an intraday peak of Rs 308 on 30 Jul 2026, Artemis Medicare Services Ltd has marked a significant milestone by hitting a fresh 52-week high. This achievement comes amid a backdrop of sustained price momentum and a confluence of bullish technical indicators, underscoring the stock’s robust upward trajectory over recent sessions.

With a decisive surge to Rs 305.55 on 29 Jul 2026, Artemis Medicare Services Ltd has reached a fresh 52-week high, propelled by a confluence of robust technical indicators and sustained price momentum that outpaces its sector and the broader market.

The Sensex advanced 1.1% on 29 Jul 2026, yet Artemis Medicare Services Ltd outpaced the broader market with an 8.23% gain, reaching an intraday high of Rs 297.5. This 6.6 percentage-point outperformance over the Hospital sector signals a distinctly stock-specific rally rather than a mere market tailwind.

Artemis Medicare Services Ltd has recently experienced a notable shift in its technical momentum, upgrading from a mildly bullish to a bullish trend. This change is supported by a combination of technical indicators including MACD, moving averages, and Bollinger Bands, signalling growing investor confidence despite a slight dip in the stock price on 29 Jul 2026.

Artemis Medicare Services Ltd, a small-cap player in the hospital sector, has exhibited a subtle shift in its technical momentum, moving from a bullish to a mildly bullish stance. Recent technical indicators reveal a complex interplay of signals, suggesting cautious optimism for investors as the stock navigates key resistance levels and market dynamics.

Artemis Medicare Services Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 24 July 2026, providing investors with the latest insights into its performance and outlook.

Artemis Medicare Services Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 13 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Artemis Medicare Services Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators that suggest an improving outlook for this small-cap hospital sector stock. Recent upgrades in its technical grade and positive price action have caught the attention of investors seeking growth opportunities in healthcare services.

Artemis Medicare Services Ltd, a small-cap player in the hospital sector, has experienced a nuanced shift in its technical momentum, reflecting a transition from a bullish to a mildly bullish trend. Despite a day decline of 3.34%, the stock’s technical indicators present a complex picture, with mixed signals across weekly and monthly timeframes, suggesting cautious optimism for investors.

Artemis Medicare Services Ltd has witnessed a notable shift in its technical momentum, with key indicators signalling an increasingly bullish trend. The stock’s recent upgrade from Hold to Buy by MarketsMOJO, alongside a Mojo Score of 78.0, underscores growing investor confidence amid mixed but improving technical signals across weekly and monthly timeframes.

Artemis Medicare Services Ltd is rated Buy by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 02 July 2026, providing investors with the most recent and relevant data to assess the company’s prospects.

Artemis Medicare Services Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of June 2026. Despite a slight dip in daily price, key indicators such as MACD, moving averages, and Bollinger Bands reveal a complex interplay of bullish and bearish signals, reflecting cautious optimism in this small-cap hospital sector stock.